Dogwood Therapeutics climbs after shareholder swaps debt for equity

Dogwood Therapeutics

12/03/2025 14:21

** Shares of drug developer Dogwood Therapeutics DWTX.O rise ~13% to $12.59

** Co's largest shareholder, CK Life Sciences, is converting a $19.5 mln loan into preferred equity stock

** DWTX says it is issuing 284.2638 shares of preferred stock to CK Life Sciences, which owns 15.9% of co's outstanding shares - LSEG

** Co says it can now focus on its mid-stage clinical trial for its pain treatment drug, Halneuron, which targets chemotherapy-induced neuropathic pain

** DWTX fell ~83% in 2024

 (Reporting by Kamal Choudhury in Bengaluru)

 ((Kamal.Choudhury@thomsonreuters.com;))